Form 8-K - Current report:
SEC Accession No. 0001558370-21-008053
Filing Date
2021-06-07
Accepted
2021-06-07 14:29:58
Documents
6
Period of Report
2021-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210607x8k.htm 8-K 40953
2 EX-10.1 tmb-20210607xex10d1.htm EX-10.1 569737
3 EX-99.1 tmb-20210607xex99d1.htm EX-99.1 100795
4 GRAPHIC tmb-20210607xex10d1002.jpg GRAPHIC 11004
5 GRAPHIC tmb-20210607xex99d1001.jpg GRAPHIC 9920
6 GRAPHIC tmb-20210607xex99d1002.jpg GRAPHIC 748
  Complete submission text file 0001558370-21-008053.txt   743187
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 21999168
SIC: 2836 Biological Products, (No Diagnostic Substances)